Home
  • Health & Wellness
  • Conditions
  • Insurance & Money

Leavitt Promotes Personalized Medicine

Home » Personal Health » Prescription Drugs

All About:
  • Prescription Drugs

Submitted by hareyan on Dec 1st, 2007
Posted under:
  • Prescription Drugs

Personalized Medicine

HHS Secretary Mike Leavitt on Thursday at a Harvard Medical School conference said personalizedmedicine is necessary to help transform the health care system into one thatpromotes value, rather than volume, the Boston Globe reports. According to Leavitt, the Human Genome Project and related research efforts can deliver on the promise of personalizedmedicine only through a transformation of the health care system to one thatpromotes improved care for patients, rather than more care for more patients.He said that the health care system should focus on four areas: electronichealth records, standardized measures of quality, transparency of prices andincentives to promote higher-quality, lower-cost care.

"I am persuaded that personalized health care creates value," Leavittsaid, adding, "The goal is to have better health care at lower cost forevery American" (Cooney, Boston Globe, 11/29).

Framingham Heart Study To Examine GeneticFactors

In related news,researchers on Thursday celebrated the 60th anniversary of the ongoing Framingham Heart Study and said the study will begin toexamine genetic factors linked with diseases as part of a program calledFramingham SHARe, the AP/Los Angeles Times reports. For the study, which beganin 1948, researchers at the Boston University School of Medicine have trackedthe lifestyles and medical histories of more than 14,000 residents of Framingham, Mass.The study, sponsored by the National Heart,Lung and Blood Institute at NIH, has led to more than 1,200 scientific papersand has helped determine risk factors for cardiovascular disease -- such assmoking, hypertension and high cholesterol levels.

Leavitt said, "When health researchers hear the words 'Framingham study,' it's like 24-caratgold," adding, "The consistency and data that's come from that longperiod cannot be replaced." Christopher O'Donnell, director of FraminghamSHARe, said, "When we find something in Framingham, you know you're findingsomething that's likely to be seen in the general population," adding,"It's a real-life laboratory, if you will, of the genetics ofdisease" (Lindsay, AP/Los Angeles Times, 11/30).

Reprintedwith permission from kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, and sign upfor email delivery at kaisernetwork.org/email . The Kaiser Daily Health PolicyReport is published for kaisernetwork.org, a free service of The Henry J.Kaiser Family Foundation. 2007 Advisory Board Company and Kaiser FamilyFoundation. All rights reserved.

Source: 
kaisernetwork.org
  • Login or register to post comments
Write For EmaxHealth

Similar Stories

  • Mental Health Problems Linked To Chantix, Zyban
  • Biological Warfare In Bacteria - Hope For New Antibiotics
  • Radioactive Substances Go Missing
  • Piroxicam No Longer Used For Acute Pain, Inflammation
  • Antibiotics Take Toll On Beneficial Gut Microbes

Enter your email address:

 Subscribe in a reader
  • ETHEX Recalls Morphine Tablets
  • FDA Announces New Labeling Changes For Regranex
  • Overwhelming Support For Follow-On Biologics To Reduce Drug Cost
  • FreshFx In Scalder Reduces Pathogens In Evisceration
  • Drug Mega-Doses May Induce Side Effects
  • FDA Approves Carbinoxamine Maleate Tablet
  • FDA Approves Potassium Chloride Extended-Release Capsules
  • Privacy Policy
  • Disclaimer
  • About Us
  • Editorial Review Process
  • Advertise
  • Contact
  • Contributors
  • Health RSS Feeds